Masato Mizuashi

7PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical anthropologyDermatologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2026
Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata.

Rie Ueki, Masato Mizuashi, Kazutoshi Harada

|Sep 11, 2025
Baricitinib 2 mg/day as a Cost-conscious Entry Point to Systemic Therapy in Moderate-to-severe Atopic Dermatitis: Real-world Data from a Japanese Clinic.

Masato Mizuashi

|Jul 23, 2025
Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version.

Manabu Ohyama, Taisuke Ito, Yasuyuki Amoh

|Jun 20, 2025
Long-Term Real-World Outcomes of Baricitinib in Severe Alopecia Areata: A 104-Week Retrospective Analysis From a Single Institute.

Moyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine

|Sep 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.

Natasha Mesinkovska, Brett King, Xingqi Zhang

|Oct 28, 2022
Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis.

Hitoshi Terui, Kenshi Yamasaki, Moyuka Wada-Irimada

Pageof 2

Frequent Collaborators

3 joint publications

Moyuka Wada-Irimada

2 joint publications

Toshiya Takahashi

2 joint publications

Kenshi Yamasaki

2 joint publications

Kazutoshi Harada